Short-Term Glycemic Effects of Liquid Metformin vs Standard Tablets

Summary

This is an open-label, randomized study evaluating the short-term glycemic effects of two concentrations of liquid metformin formulations (100 mg/mL and 250 mg/mL) compared with standard immediate-release metformin tablets in healthy adult subjects. Participants will receive single or short-term doses of study treatments in a randomized sequence. Blood glucose measurements and other glycemic indicators will be collected to assess short-term pharmacodynamic effects. Safety and tolerability will also be monitored.

Timeline

Start

2026-07-15

Primary completion

2026-08-15

Completion

2026-08-28

Drugs

Indications

No indication recorded.